DLO’s Response to Coronavirus Disease 2019 (COVID-19)
Information updated at 10:25 p.m. on March 25, 2020
Coronavirus Disease 2019 or COVID-19 (formally known as 2019-nCoV) is the name for the respiratory syndrome caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Diagnostic Laboratory of Oklahoma (DLO) is monitoring the situation closely and bolstering our preparedness. Our priority is the health and safety of our employees, patients and the communities we serve. The content below provides information for providers and others to help guide their management of patients. We encourage providers to periodically check this web page for updates on our response.
New Test for COVID-19
Through our relationship with Quest Diagnostics, DLO began testing for COVID-19 on March 9. This test is to be performed only using respiratory specimens collected from individuals who meet CDC clinical and/or epidemiological criteria for COVID-19 testing. DLO Patient Service Centers and other phlebotomy sites cannot collect specimens for this test.
Patients: Please do not go to a DLO Patient Service Center for COVID-19 testing as these sites do not collect specimens for COVID-19 testing. Contact your healthcare provider for information about testing.
We invite you to read the Quest Diagnostics press release for more information.
Helpful Coronavirus Links
- Centers for Disease Control and Prevention (CDC)
- Quest Diagnostics (Healthcare Providers)
- Quest Diagnostics (Patients)
- Oklahoma State Department of Health
Still have questions?
For answers to more questions about COVID-19, healthcare providers and patients are welcome to call 866-404-1550, the national call center provided by Quest Diagnostics. This call center can provide answers to many questions, but they cannot provide answers regarding patient results.